CAS

Recent progress in oncological pharmacotherapy has resulted in more complex treatment options and adverse event management, widening gaps in care quality between specialised centres and local hospitals. Although comprehensive genomic profiling (CGP) expands access to clinical trials, insufficient...

Recent progress in oncological pharmacotherapy has resulted in more complex treatment options and adverse event management, widening gaps in care quality between specialised centres and local hospitals. Although comprehensive genomic profiling (CGP) expands access to clinical trials, insufficient information-sharing continues to limit access to appropriate trials – particularly in rare cancers or low-frequency genetic mutations (rare fractions), where geographical barriers further limit opportu

• pharmaphorum media limited Rosemount House Rosemount Avenue West Byfleet, Surrey KT14 6LB United Kingdom
• 1

Visit Website Linkedin